Imperial College London
Portrait Picture

Dr Sabine L. van Elsland

Faculty of Medicine, School of Public Health

External Relationships & Communications Manager
 
 
 
//

Contact

 

+44 (0)20 7594 3896s.van-elsland

 
 
//

Location

 

G35Medical SchoolSt Mary's Campus

//

Summary

 

Publications

Citation

BibTex format

@article{van:2018:10.5588/ijtld.18.0236,
author = {van, Elsland SL and van, Dongen SI and Bosmans, JE and Schaaf, HS and van, Toorn R and van, Furth AM},
doi = {10.5588/ijtld.18.0236},
journal = {Int J Tuberc Lung Dis},
pages = {1188--1195},
title = {Cost-effectiveness of home-based vs. in-hospital treatment of paediatric tuberculous meningitis.},
url = {http://dx.doi.org/10.5588/ijtld.18.0236},
volume = {22},
year = {2018}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - SETTING: Cape Town, South Africa, 2014. OBJECTIVE: To assess the societal costs and cost-effectiveness of home-based vs. in-hospital treatment of paediatric tuberculous meningitis. DESIGN: This was an economic evaluation from a societal perspective using probabilistic analysis. Health care, informal care, lost productivity costs and costs in other sectors, health-related quality of life (HRQoL) and family impact were assessed during interviews with care givers, children, medical staff and management. RESULTS: Societal costs for home-based treatment were USD3857, and USD28 043 for in-hospital treatment. Home-based vs. in-hospital treatment HRQoL scores were 90.9% vs. 84.5%, while family impact scores were 94.8% vs. 73.1%. The point estimate of the incremental cost-effectiveness ratio indicated that improving HRQoL and family impact by 1% was associated with a saving of respectively USD3726 and USD1140 for home-based vs. in-hospital treatment. The probability that home-based treatment was less expensive and more effective than in-hospital treatment was 96.3% for HRQoL and 100% for family impact. CONCLUSION: Societal costs of home-based treatment were lower than for in-hospital treatment. Children treated at home had a better HRQoL and family impact scores. Home-based treatment was a cost-effective alternative to in-hospital treatment of drug-susceptible tuberculous meningitis.
AU  - van,Elsland SL
AU  - van,Dongen SI
AU  - Bosmans,JE
AU  - Schaaf,HS
AU  - van,Toorn R
AU  - van,Furth AM
DO  - 10.5588/ijtld.18.0236
EP  - 1195
PY  - 2018///
SP  - 1188
TI  - Cost-effectiveness of home-based vs. in-hospital treatment of paediatric tuberculous meningitis.
T2  - Int J Tuberc Lung Dis
UR  - http://dx.doi.org/10.5588/ijtld.18.0236
UR  - https://www.ncbi.nlm.nih.gov/pubmed/30236187
VL  - 22
ER  -
Download